Clinical Trial Update: Modified-FOLFIRINOX Regimen Based Neoadjuvant Therapy in Chinese Patients With Locally Advanced Pancreatic Cancer

View source ↗

Summary

Completed clinical trial in Chinese patients evaluating a modified-FOLFIRINOX neoadjuvant regimen for locally advanced pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Pancreatic Cancer, Chemotherapy Effect | Status: COMPLETED